[HTML][HTML] The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections
T Tängdén, V Ramos Martín, TW Felton… - Intensive care …, 2017 - Springer
Critically ill patients with severe infections are at high risk of suboptimal antimicrobial dosing.
The pharmacokinetics (PK) and pharmacodynamics (PD) of antimicrobials in these patients …
The pharmacokinetics (PK) and pharmacodynamics (PD) of antimicrobials in these patients …
Meropenem use and therapeutic drug monitoring in clinical practice: a literature review
NA Steffens, ES Zimmermann… - Journal of clinical …, 2021 - Wiley Online Library
What is known and objective Meropenem, a carbapenem antibiotic, is widely prescribed for
the treatment of life‐threatening infections. The main parameter associated with its …
the treatment of life‐threatening infections. The main parameter associated with its …
Therapeutic drug monitoring of β-lactam antibiotics in the critically ill: direct measurement of unbound drug concentrations to achieve appropriate drug exposures
G Wong, S Briscoe, B McWhinney, M Ally… - Journal of …, 2018 - academic.oup.com
Objectives To describe the achievement of unbound β-lactam antibiotic concentration
targets in a therapeutic drug monitoring (TDM) programme in critically ill patients, and the …
targets in a therapeutic drug monitoring (TDM) programme in critically ill patients, and the …
[HTML][HTML] Multidrug resistance (MDR) and collateral sensitivity in bacteria, with special attention to genetic and evolutionary aspects and to the perspectives of …
Antibiotic poly-resistance (multidrug-, extreme-, and pan-drug resistance) is controlled by
adaptive evolution. Darwinian and Lamarckian interpretations of resistance evolution are …
adaptive evolution. Darwinian and Lamarckian interpretations of resistance evolution are …
[HTML][HTML] Precision dosing software to optimize antimicrobial dosing: a systematic search and follow-up survey of available programs
NGL Jager, MG Chai, RM van Hest, J Lipman… - Clinical Microbiology …, 2022 - Elsevier
Background Precision dosing programs are promising tools for optimising antimicrobial
dosing. Selecting the ideal program for local application may be challenging due to the large …
dosing. Selecting the ideal program for local application may be challenging due to the large …
Pharmacodynamic target attainment for cefepime, meropenem, and piperacillin-tazobactam using a pharmacokinetic/pharmacodynamic-based dosing calculator in …
EL Heil, DP Nicolau, A Farkas… - Antimicrobial Agents …, 2018 - Am Soc Microbiol
This was a prospective study to determine if pharmacokinetic/pharmacodynamic (PK/PD)-
based antibiotic dosing software aids in achieving concentration targets in critically ill …
based antibiotic dosing software aids in achieving concentration targets in critically ill …
Pharmacokinetics/pharmacodynamics of β-lactams and therapeutic drug monitoring: from theory to practical issues in the intensive care unit
P Williams, MO Cotta, JA Roberts - Seminars in Respiratory and …, 2019 - thieme-connect.com
Despite therapeutic advances over recent decades, the mortality rate for sepsis and septic
shock is still approximately 25% worldwide. Early administration of appropriate intravenous …
shock is still approximately 25% worldwide. Early administration of appropriate intravenous …
[HTML][HTML] Development and evaluation of uncertainty quantifying machine learning models to predict piperacillin plasma concentrations in critically ill patients
J Verhaeghe, SAM Dhaese, T De Corte… - BMC Medical Informatics …, 2022 - Springer
Background Beta-lactam antimicrobial concentrations are frequently suboptimal in critically
ill patients. Population pharmacokinetic (PopPK) modeling is the golden standard to predict …
ill patients. Population pharmacokinetic (PopPK) modeling is the golden standard to predict …
Pharmacodynamic attainment of the synergism of meropenem and fosfomycin combination against Pseudomonas aeruginosa producing metallo-β-lactamase
J Albiero, J Mazucheli, JPR Barros… - Antimicrobial Agents …, 2019 - Am Soc Microbiol
Fosfomycin combined with other antimicrobials has shown good efficacy against multidrug-
resistant (MDR) bacteria in both in vitro and clinical studies; however, the activity of …
resistant (MDR) bacteria in both in vitro and clinical studies; however, the activity of …
Pharmacodynamic evaluation of the potential clinical utility of fosfomycin and meropenem in combination therapy against KPC-2-producing Klebsiella pneumoniae
J Albiero, SKB Sy, J Mazucheli… - Antimicrobial Agents …, 2016 - Am Soc Microbiol
ABSTRACT KPC-producing Klebsiella pneumoniae causes serious infections associated
with high death rates worldwide. Combination therapy consisting of fosfomycin and a …
with high death rates worldwide. Combination therapy consisting of fosfomycin and a …